WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 9'8801 Infant (under 12 months) mortality rate: 82
GDP / capita (US$): 17'6031 Child (under 5 years) mortality rate: 92

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 4'966  4'822  4'647  4'478  4'341  3'235  2'703  2'605 
Births 65  64  62  60  57  62  68  78 
Surviving infants 65  63  61  59  57  61  66  75 
Pop. less than 5 years 321  302  281  269  273  305  311  366 
Pop. less than 15 years 1'000  1'004  1'003  1'009  1'029  927  923  1'017 
Female 15-49 years 1'431  1'372  1'303  1'232  1'168  885  688  626 

Number of reported case

(Click for retrospective incidence data for Lebanon)
Diphtheria
Japanese encephalitis
Measles 112  1'761  12 
Mumps 14  12  12  28  23 
Pertussis 58  53  19 
Polio*
Rubella 18  27 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)**
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Lebanon)
Vaccine year result method % card seen                                                
BCG         
DTP1 2008  84  MICS   55  96  99*  99  98  98  93 
DTP3 2008  72  MICS   55  97  98  95  95  94  90  82 
DTP4          91 
IPV1          98 
HepB_BD          99*  99*  94  99  98  90 
HepB3 2008  72  MICS   55  97  98  95  95  94  70 
Hib3 2008  72  MICS   55  97  98  95  95  94 
JapEnc         
MCV1          98  99  98  98  95  90  39 
MCV2          69  79  88  86  89  87 
PCV1         
PCV3         
Pol3 2008  74  MICS   55  97  99*  96  96  94  90  82 
Rota1         
Rota_last         
Rubella1          98  99  98  98  95 
TT2plus         
PAB         
VAD1         
YFV 2003  50  PAPFAM   62 
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Lebanon)
DTP1 84  84  84  84  84  90  94  17 
DTP3 81  81  81  81  81  83  82 
HepB3 81  81  81  81  81  83 
HepB_BD 94  94  94  94  94  90 
Hib3 81  81  81  81  81 
MCV1 79  79  79  79  79  71  61 
MCV2 75  75  75  75  75  56 
PCV3
Pol3 75  75  75  75  75  83  82 
Rota_last

Number of districts in the country 26  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG No displaced syrians
DT Yes children having problem/pertussis
DTwP 4-5 years; Yes
DTwPHibHepB 2, 4, 6, 18 months; Yes
HepB birth; Yes and medical and paramedics+dialysis
IPV 2 months; Yes
MMR 1, 4-5 years; Yes
Measles 9 months; Yes
MenACWY Yes Haj pilgrimage
OPV 4, 6, 18 months; 4-5, 10-12, 16-18 years; Yes
Pneumo_conj 4, 6, 12 months Yes From June 2015
Td 10-12, 16-18 years; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2010-2015  2010-2014  2010-2014  2010-2014  2010-2014  2010- 2014  2009-2013 
Nº of districts with microplans that include activities to raise immunization coverage number 26  25  20  18  17  15  25 

System performance

Total Nº districts in country number 26  26  26  26  26  26  26 
Nº districts with DTP3 coverage >=80% number 26  26  26  26  25  26 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  96  100 
Nº districts with measles (MCV1) coverage >=95% number 20  18  11  12 
% of districts with MCV1 coverage >=95% From 0 to 100% 27  77  69  23  35  42  46 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100    100  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.